Ema AI, an enterprise platform for agentic AI employees, has appointed Jonathan Feldman as Head of Revenue, Partnerships and Solutions. The role was created to support the company's expansion of enterprise adoption for its AI employees in HR, IT and finance. Feldman joins from Workato, where he spent four years, most recently as Global Vice President of the AI business unit. At Workato, he built the AI business unit from the ground up and developed strategic partnerships with Anthropic, OpenAI, Google and Nvidia. In his new role, Feldman will lead Ema's revenue, partnerships and solutions organisation, with responsibility for building a scalable partner ecosystem and creating a repeatable enterprise go-to-market motion. Prior to Workato, he held enterprise sales leadership roles at Freshworks, Oracle and SAP. Ema's platform provides enterprise-grade orchestration and pre-built AI employees designed to support business workflows.

Hospital for Special Surgery (HSS) is deploying AI agents for patient scheduling and triage through a collaboration with Ema Unlimited. The 24/7 service uses conversational AI to assess patient conditions via web, text or phone, then books appointments with appropriate clinicians based on location, insurance and availability. The system includes safeguards, with complex cases escalated to human specialists. All AI decisions are auditable and patient data remains secure. HSS filters technology decisions through an AI subcommittee that scrutinises patient-facing applications rigorously. HSS plans to open a dedicated AI lab at its New York campus to democratise access across staff. Dr Barad, who co-chairs the AI subcommittee, emphasises treating agentic AI as general-purpose technology requiring unified data strategy rather than narrow use cases.

Willow Innovations and Ema EQ have launched the Women's Health AI Consortium, the first industry body dedicated to establishing standards and ethical guidelines for AI in women's health. The consortium addresses the historic underinvestment in women's health technology, where AI tools are often built on incomplete data and deployed without sufficient oversight. The initiative is governed by a multidisciplinary board including clinicians, technologists and ethicists. It operates around six core commitments focused on accuracy benchmarks, data transparency and clinical validation. The consortium aims to ensure AI tools reflect women's lived experiences and meet safety standards before widespread deployment. "Women's health AI is moving at a pace that demands immediate, coordinated accountability," says Sarah O'Leary, CEO of Willow. The consortium provides shared standards for organisations developing or deploying AI in women's health.